Key result
A stepwise percutaneous strategy of coarctation stenting followed by TAVR improved left ventricle ejection fraction from 12% to 32% in a patient with complex structural heart disease.
Why the study?
Bicuspid aortic valve and coarctation commonly coexist, but diagnosis in the eighth decade of life is exceptionally rare.
Does a stepwise percutaneous strategy (coarctation stenting followed by TAVR) improve procedural success and left ventricular function in a high-risk patient with severe bicuspid aortic stenosis, aortic coarctation, and severely impaired LVEF?
Case Report (n=1)
Does a stepwise percutaneous strategy (coarctation stenting followed by TAVR) improve procedural success and left ventricular function in a high-risk patient with severe bicuspid aortic stenosis, aortic coarctation, and severely impaired LVEF?
A stepwise percutaneous approach, treating coarctation first, can safely facilitate TAVR and improve systolic function in high-risk patients with coexisting severe bicuspid aortic stenosis, aortic coarctation, and severely impaired LVEF.
May support staged repair in select high-risk cases; hypothesis-generating and requires prospective validation.
BACKGROUND: While bicuspid aortic valve and coarctation commonly coexist, diagnosis in the eighth decade of life is exceptionally rare. CASE SUMMARY: A 78-year-old male patient with a history of hypertension was admitted with a 2-year history of progressive dyspnea on minimal exertion. After diagnostic workup, he was diagnosed with severe bicuspid aortic stenosis, aortic coarctation, and severely impaired left ventricle systolic function (left ventricle ejection fraction 12%). Due to high surgical risk, a stepwise percutaneous strategy was adopted, starting with coarctation stenting which improved the left ventricle ejection fraction to 32%, allowing for successful transcatheter aortic valve replacement using a snare-assisted technique. DISCUSSION: Treating the coarctation first facilitated valve delivery and reduced afterload, improving systolic function, and ultimately reducing the need for ventricular support during transcatheter aortic valve replacement. TAKE-HOME MESSAGE: A stepwise approach is crucial in managing high-risk patients with complex structural heart disease, demonstrating the importance of meticulous preprocedural planning.
No takes yet. Share an insight, caveat, or question.
Pérez-Orpinel et al. (2025) conducted a case report in Severe bicuspid aortic stenosis, aortic coarctation, and impaired left ventricular function (n=1). Stepwise percutaneous strategy (coarctation stenting followed by TAVR) was evaluated on Left ventricle ejection fraction improvement. A stepwise percutaneous strategy of coarctation stenting followed by TAVR improved left ventricle ejection fraction from 12% to 32% in a patient with complex structural heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: